medigraphic.com

2019, Number 2

<< Back Next >>

Rev Mex Anest 2019; 42 (2)

Answering the question: is metamizole a non-steroidal anti-inflammatory or not?

Carrillo-Torres O, Molina-García R, Rascón-Martínez DM, Díaz-Mendoza A

Language: Spanish
References: 20
Page: 98-103
PDF size: 186.08 Kb.


ABSTRACT

The aim of this article is to know the importance of metamizol as analgesic in Mexico, knowing the frequency of their use and the mechanisms of action and to adequately classify the drug in the pharmacopoeia of painkillers. Few drugs generate discussion about their parentage but metamizol from that hits the market in 1922 until today, it has no clearly defined. Commonly when NSAIDs rated seeks to metamizol is classified within the same as pyrazolone derivatives. We then start with the pharmacological aspects and later to know the similarities and differences with other NSAIDs and can draw appropriate conclusions. Even so, the medicine is one of the most used by physicians in second and third level hospitals (82%), although most do not really know what their mechanism of action is (91%), so the importance of knowing the mechanism of action of this drug.


REFERENCES

  1. García-Martínez JM, Fresno-Vara JA, Lastres P, Bernabéu C, Ortiz-Betés P, Martín-Pérez J. Effect of metamizol on promyelocytic and terminally differentiated granulocytic cell comparative analysis with acetylsalicylic acid and diclofenac. Biochemical Pharmacology. 2003;65:209-217.

  2. Stammschulte T, Ludwig WD, Mühlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol. 2015;15.

  3. COFEPRIS. Comunicado a los profesionales de la salud, recomendación del uso de metamizol. 2010. Disponible en: http://201.147.97.109:8080/ReaccionesAdversas/Prof1

  4. Levy M, Brune K, Zylber-Katz E, Cohen O, Caraco Y, Geisslinger G. Cerebrospinal fluid prostaglandins after systemic dipyrone intake. Clin Pharmacol Ther. 1998;64:117-122.

  5. Cohen O, Zylber-Katz E, Caraco Y, Granit L, Levy M. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone. Eur J Clin Pharmacol. 1998;54:549-553.

  6. Kassian-Rank A. Los analgésicos antiinflamatorios no esteroideos. Foro de investigación y tratamiento de dolor para la comunidad médica. 2013: 5-13. Disponible en: http://132.248.9.34/hevila/DolorclinicayterapiaRevistamexicanadealgologia/2002-03/vol1/no2/1.pdf

  7. Bentur Y, Cohen O. Dipyrone overdose. J Toxicol. 2004;42:261-265.

  8. Hinz B, Cheremina O, Bachmakov J, Renner B, Zolk O, Fromm MF, et al. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J. 2007;21:2343-2351.

  9. Levy M, Zylber-Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet. 1995;28:216-234.

  10. Pierre SC, Schmidt R, Brenneis C, Michaelis M, Geisslinger G, Scholich K. Inhibition of cyclooxygenases by dipyrone. British Journal of Pharmacology. 2007;151:494-503.

  11. Ortiz MI, Castañeda-Hernández G, Granados-Soto V. Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels. Pharmacol Biochem Behav. 2003;74:465-470.

  12. dos Santos GG, Dias EV, Teixeira JM, Athie MC, Bonet IJ, Tambeli CH, et al. The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: neuronal K(ATP) channel opening and CB(1) receptor activation. Eur J Pharmacol. 2014;741:124-131.

  13. Beirith A, Santos AR, Rodrigues AL, Creczynski-Pasa TB, Calixto JB. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol. 1998;345:233-245.

  14. Tortorici V, Vanegas H. Opioid tolerance induced by metamizol (dipyrone) microinjections into the periaqueductal grey of rats. Eur J Neurosci. 2000;12:4074-4080.

  15. Vázquez E, Hernandez N, Escobar W, Vanegas H. Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res. 2005;1048:211-217.

  16. Escobar W, Ramirez K, Avila C, Limongi R, Vanegas H, Vazquez E. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats. Eur J Pain. 2012;16:676-689.

  17. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: A randomized, double blind, placebo controlled study. Headache. 2002;42:862-871.

  18. Malvar Ddo C, Soares DM, Fabrício AS, Kanashiro A, Machado RR, Figueiredo MJ, et al. The antipyretic effect of dipyrone is unrelated to inhibition of PGE(2) synthesis in the hypothalamus. Br J Pharmacol. 2011;162:1401-1409.

  19. Ministerio de Sanidad, Política Social e Igualdad. Agencia Española de Medicamentos y Productos Sanitarios. Disponible en: https://botplusweb.portalfarma.com /documentos/ 2014/10/28/78380.pdf

  20. Pogatzki-Zahn E, Chandrasena C, Schug SA. Nonopioid analgesics for postoperative pain management. Curr Opin Anaesthesiol. 2014;27:513-519.




2020     |     www.medigraphic.com